EcoDrugPlus

Protein Arginine Methyltransferase 5

Ensembl ID : ENSSAUG00010018781
Gene Symbol: PRMT5
3 Cross references
198 Possible Orthologues:

Protein Farnesyltransferase Subunit Beta-Like

Ensembl ID : ENSSAUG00010015931
Gene Symbol: LOC115574475
3 Cross references
209 Possible Orthologues:

Protein Kinase C Alpha

Ensembl ID : ENSSAUG00010005316
Gene Symbol: PRKCA
3 Cross references
213 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSSAUG00010021140
Gene Symbol: PRKCB
3 Cross references
207 Possible Orthologues:

Protein Kinase C Beta Type

Ensembl ID : ENSSAUG00010009330
Gene Symbol: LOC115579038
3 Cross references
223 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSSAUG00010009880
Gene Symbol: PRKCD
3 Cross references
203 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSSAUG00010014159
Gene Symbol: PRKCD
3 Cross references
204 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSSAUG00010026849
Gene Symbol: PRKCE
3 Cross references
249 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSSAUG00010017807
Gene Symbol: PRKCE
1 Cross references
252 Possible Orthologues:

Protein Kinase C Eta

Ensembl ID : ENSSAUG00010016286
Gene Symbol: PRKCH
3 Cross references
224 Possible Orthologues:

Protein Kinase C Theta

Ensembl ID : ENSSAUG00010020355
Gene Symbol: PRKCQ
3 Cross references
204 Possible Orthologues:

Protein Kinase C Zeta

Ensembl ID : ENSSAUG00010022848
Gene Symbol: PRKCZ
3 Cross references
201 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).